Zepp Health Corporation Sponsored ADR ZEPP

4.14 0.02 0.49% as of 25 Sep
Market cap
$34.9M
P/E
0.0×

Insider Decisions

Total sells 0.05
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — 1 — — —
Insider Ownership 46.51%

Capital & Financial Ratios

Market Cap 34.94
Revenue 276.03
Net Income (40.07)
Free Cash Flow (119.99)
Net Debt 26.97
Current Ratio 0.90
Debt/Equity 0.72
P/E ratio 0.00
P/S ratio 0.24
P/B ratio 0.35
Past 5Y EPS Growth —
This Y EPS Growth 75.00%
Next Y EPS Growth 266.67%
Next 5Y EPS Growth 8.71%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 0.00
0.40
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 146 112 113 106
Receivables 69 66 74 83
Inventory 85 57 73 62
Other — — — —
317 252 294 283
2023 2024 2025 Q'26
Payables 37 51 81 88
ST’ Debt 2 42 56 77
Other 0 0 0 0
155 195 287 314
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — (23.47%) (24.46%)
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — (12.51%) (18.01%)

Revenue

Mar Jun Sep Dec Year
’26 52 64 — — —
’25 39 59 76 85 259
’24 40 41 42 60 183
’23 94 92 83 83 353
’22 119 165 170 146 601
’21 175 284 249 260 981
’20 154 161 329 342 986
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — (26) (26)
’24 — — — (24) (24)
’23 — — — 43 43
’22 — — — (114) (114)
’21 — — — — (36)
’20 — — — 24 24
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — (26) (26)
’24 — — — (24) (24)
’23 — — — 46 46
’22 — — — (116) (116)
’21 — — — — (44)
’20 — — — 11 11
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (1.24) (0.72) — — —
’25 (1.23) (0.49) (0.10) (0.69) (2.52)
’24 (0.92) (0.68) (0.82) (2.29) (4.68)
’23 (1.28) (0.64) 0.02 (0.08) (1.96)
’22 (0.88) (1.04) (0.16) (0.72) (2.72)
’21 (0.40) 0.88 0.44 0.09 1.32
’20 0.16 0.12 0.72 1.08 2.16
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — 33.72 29.08 35.00 17.04 4.20 3.86 2.06 2.13

Analyst estimates 2026–2028

Powerpack
Low Price
— — 60.36 78.64 72.82 81.00 21.56 8.76 8.40 61.85
High Price
376 416 694 1,132 1,507 1,227 987 839 765 763
Employees
1 1 1 1 1 1 1 0 0 0
Revenue/Emp
234 315 530 835 986 981 601 353 183 259
Revenue
17.74% 24.14% 25.77% 25.25% 20.71% 20.89% 19.39% 26.17% 38.46% 38.31%
Gross Margin
4 29 56 94 41 17 (54) (35) (58) (35)
EBT
1.85% 9.37% 10.61% 11.22% 4.13% 1.71% (8.99%) (9.81%) (31.71%) (13.70%)
EBT Margin
4 26 49 82 35 21 (42) (31) (76) (40)
Net Income
0 1 1 2 4 8 8 8 5 5
Depreciation
67.31 74.34 40.04 54.83 63.49 62.23 39.02 23.22 11.29 16.28
Revenue/Sh
1.04 1.68 3.48 5.40 2.24 1.36 (2.72) (1.96) (4.68) (2.52)
Earnings/Sh
0.75 8.65 7.77 4.04 1.55 (2.31) (7.42) 2.80 (1.51) (1.62)
Cash Flow/Sh
(0.50) (0.78) (0.76) (0.43) (0.84) (0.50) (0.09) 0.20 0.02 (0.01)
Capex/Sh
0.25 7.87 7.01 3.60 0.72 (2.82) (7.51) 3.00 (1.49) (1.63)
Free CF/Sh
1.30 8.28 19.88 23.56 26.94 29.21 25.29 23.21 15.62 13.49
Book Value/Sh
3 4 13 15 16 16 15 15 16 16
Shares
0.00 0.13 11.54 8.97 21.94 19.80 0.00 0.00 0.00 0.00
PE Ratio
0.00 0.00 0.98 0.88 0.75 1.32 0.16 0.25 0.23 1.65
PS Ratio
0.00 0.02 1.98 2.04 1.76 2.79 0.25 0.25 0.17 2.00
PB Ratio
0.00 0.00 0.54 0.58 0.48 1.28 0.32 0.18 0.26 1.66
EV/Sales
0.00 0.00 2.14 2.56 3.10 8.17 4.52 (15.95) (0.57) (3.59)
EV/FCF
3 37 103 61 24 (36) (114) 43 (24) (26)
Op' Cash Flow
(2) (3) (10) (7) (13) (8) (1) 3 0 0
Capex
1 33 93 55 11 (44) (116) 46 (24) (26)
FCF
34 64 214 274 312 279 187 162 56 7
Working Cap'
2 6 6 16 94 201 245 122 117 115
Total Debt
(23) (53) (227) (246) (259) (40) 99 (24) 5 2
Net Debt
5 35 263 359 418 460 389 353 253 215
Sh' Equity
(0.98%) 3.82% 4.72% 13.52% 4.25% 2.33% (4.86%) (4.43%) (13.01%) (7.33%)
ROA
0.00% 0.00% 91.68% 48.12% 10.44% 2.19% (7.62%) (5.79%) (11.44%) (8.43%)
ROIC
(9.29%) 35.79% 11.07% 26.46% 9.02% 4.92% (9.84%) (8.36%) (25.02%) (17.15%)
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Zepp Health Corporation Sponsored ADR peers in Consumer Electronics

All 19 Consumer Electronics stocks →

Zepp Health Corporation Sponsored ADR (ZEPP) key facts

  • Zepp Health Corporation Sponsored ADR (ZEPP) is a Consumer Electronics company in the Technology sector, traded in the US as an ADR.
  • Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024.
  • As of September 25, 2026, ZEPP traded at $4.14, a market capitalization of $34.9 million.
  • Return on equity was −17.2% and debt-to-equity 0.72.

Source: company filings (standardised) and stockrow calculations.

Zepp Health Corporation Sponsored ADR (ZEPP) Latest News

News by impact score

Fine-tune

22 Sep

4

Amazfit, a Zepp Health-owned brand, unveils the T-Rex Dual Solar, the first AMOLED smartwatch with dual-sided solar charging. Front solar on the display and a larger rear glass-ceramic back panel extend battery life beyond typical 25 days, with three hours of 50,000 lux daily exposure boosting endurance to up to 34 days on the front; rear solar provides even more energy. Features include a 1.32-inch, up to 3,000-nit AMOLED display, 10 ATM water resistance, 50-meter diving support, a built-in flashlight, and GPS/navigation tools with preloaded maps and LiveShare. Solar Priority and Expedition modes optimize power for multi-day trips. Specs emphasize titanium bezel, sapphire crystal, 660 mAh battery, and up to 41 hours in GPS mode; price $649.99, available Sept 22, 2026 on Amazfit.com and Amazon. Dual-sided solar AMOLED watch expands product differentiation and could boost sales and investor sentiment.

2 Sep

3

Zepp Health returns to growth in Q2 2026 amid supply challenges. Return to growth signals potential recovery in financial performance despite supply constraints.

1 Sep

3 transcript

Zepp Health Corporation Sponsored ADR (ZEPP) Q2 earnings call highlights financial results and operational updates. Q2 earnings call highlights deliver performance data and guidance that moderately shift near-term investor views.

3

Zepp Health Corporation released unaudited financial results for the second quarter of 2026. Quarterly earnings reports can shift short-term stock valuation based on reported numbers.

18 Jun

3

Amazfit launches Helio Strap Pro body-worn device delivering movement intelligence for HYROX and hybrid training athletes. New product launch supports fitness tech innovation and may lift brand visibility and sales modestly.

9 Jun

4

Zepp Health reports strong revenue growth in Q1 2026 earnings call alongside strategic initiatives driving performance. Strong revenue growth and strategic moves in earnings call point to significant positive shifts in company trajectory.

8 Jun

4

Zepp Health Corporation released unaudited financial results for the first quarter of 2026. Quarterly results disclosures frequently shift investor sentiment and alter near-term stock valuation.

3

Zepp Health Q1 earnings call highlights financial results and operational updates for ZEPP ADR. Q1 earnings details deliver key financial metrics that typically influence short-term ZEPP stock sentiment without major strategic shifts.

2 Jun

4

Amazfit launches Balance 3 and Balance Ultra smartwatches to advance hybrid training features. New Amazfit Balance 3 and Balance Ultra launches represent significant product releases that can shift ZEPP competitive positioning.

13 May

4

Amazfit launched the Cheetah 2 Ultra, a performance trail running watch engineered for the toughest mountain trails with advanced features for extreme endurance. Amazfit's launch of a premium trail running watch strengthens Zepp Health's position in the competitive wearables market and could drive revenue growth.

11 May

4

Amazfit unveiled the Cheetah 2 Pro, a high-performance running watch designed for marathon preparation with advanced training metrics, AI coaching, and dual-band GPS. New Amazfit Cheetah 2 Pro launch targets competitive running segment, boosting Zepp Health's product portfolio and potential sales in wearables.

19 Apr

4

Loss-making Zepp Health Corporation (NYSE:ZEPP) is positioned to achieve breakeven, signaling a turnaround from ongoing losses. Breakeven trajectory for a loss-making company represents a major financial milestone that could boost stock performance and investor confidence.

16 Apr

4

Amazfit unveiled the Cheetah 2 Pro, a performance running watch built for marathon preparation with advanced training features. New high-end running watch launch targets competitive fitness segment and strengthens Amazfit's product portfolio for potential revenue growth.

15 Apr

4

HYROX and Amazfit strengthen their alliance through a global three-year partnership. Global three-year partnership with HYROX boosts Amazfit's fitness sector visibility and Zepp Health's competitive positioning.

17 Mar

4

Zepp Health Corp (ZEPP) reported strong revenue growth and strategic advancements in Q4 2025 earnings call highlights. Strong Q4 2025 revenue growth and strategic initiatives signal major positive shifts in ZEPP's financial trajectory and market positioning.

15 Mar

4

Zepp Health Corporation released Q4 earnings call highlights detailing financial results, operational updates, and forward-looking guidance. Q4 earnings call highlights reveal financial performance and strategic outlook, significantly impacting investor sentiment and stock trajectory.

4

Zepp Health Corporation announced unaudited financial results for Q4 and full year 2025. Q4 and full-year financial results directly impact stock price, investor sentiment, and valuation assessments.

26 Feb

4

Amazfit launched the Active 3 Premium smartwatch, targeting entry-level runners by transforming daily movement into meaningful progress with features like advanced training guidance, GPS tracking, and AI-powered coaching. New premium smartwatch launch for entry-level runners strengthens Amazfit's product lineup and could significantly enhance Zepp Health's revenue and competitive positioning in wearables.

20 Feb

4

Amazfit launched the T-Rex Ultra 2, a titanium GPS watch built for extreme adventures with advanced durability, multi-band GNSS, offline maps, and up to 27 days battery life. Premium rugged smartwatch launch bolsters Zepp Health's product portfolio and market position in wearables.

19 Feb

4

Amazfit announced the T-Rex Ultra 2, a titanium GPS watch engineered for extreme adventures, featuring advanced durability, 180-hour GPS battery life, offline maps, and dive capabilities up to 40 meters. Launch of a premium rugged smartwatch strengthens Amazfit's position in the extreme sports wearables market, likely boosting Zepp Health's sales and investor interest.

8 Jan

3

Amazfit has launched the Active Max, a new smartwatch designed for enhanced performance with a larger display and improved brightness. The device aims to cater to fitness enthusiasts by offering advanced tracking features and a robust design, positioning itself as a competitive option in the wearable technology market. The introduction of the Active Max is expected to moderately influence Zepp Health's competitive positioning and product innovation in the wearable market.

6 Jan

4

Amazfit, a brand under Zepp Health Corporation, unveiled its latest innovations in sports technology at CES 2026, showcasing advanced wearable devices designed to enhance athletic performance and health monitoring. The new products feature cutting-edge sensors and AI-driven analytics, aiming to set a new standard in the fitness tech industry. This launch positions Amazfit as a leader in the competitive landscape of sports technology, appealing to both professional athletes and fitness enthusiasts. The introduction of advanced sports technology products is likely to significantly impact Zepp Health's market positioning and investor sentiment.

30 Dec

3

Amazfit has launched the Active Max smartwatch, featuring a larger display, enhanced brightness, and advanced performance capabilities. The device is designed for fitness enthusiasts, offering improved tracking and user experience. This new addition aims to strengthen Amazfit's position in the competitive wearable market. The introduction of the Active Max smartwatch may enhance product innovation and competitive positioning but is not expected to drastically alter the company's overall trajectory.

5 Dec

4

Zepp Health Corporation Sponsored ADR (ZEPP) has achieved an astonishing nearly 1,100% gain, significantly outperforming the S&P 500. This remarkable performance is attributed to the company's innovative health technology products and strategic market positioning, which have resonated well with consumers and investors alike. As the demand for health-focused technology continues to rise, Zepp Health's growth trajectory appears promising, drawing attention from market analysts and investors seeking high-potential stocks. The significant gain and strategic positioning in a growing market indicate a likely substantial impact on future performance.

6 Nov

4

Zepp Health Corporation reported record revenue growth in Q3 2025, highlighting strategic initiatives that contributed to its performance. The company emphasized advancements in product innovation and market expansion, which have positively impacted its financial results. Management expressed optimism about future growth prospects and outlined plans for continued investment in technology and customer engagement. Record revenue growth and strategic initiatives indicate significant potential for future performance and market positioning.

4

Zepp Health Corporation (NYSE: ZEPP) reported a significant annual loss increase of 64.6%, raising concerns about its recovery prospects. The worsening financial performance has led to skepticism among investors regarding the company's ability to rebound in the competitive health technology market. The substantial increase in losses indicates a significant challenge to the company's recovery and future market performance.

4 Nov

4

Zepp Health Corporation reported its unaudited financial results for the third quarter of 2025, highlighting key metrics such as revenue growth and profitability. The company continues to expand its product offerings and market presence, reflecting a positive trajectory in its financial performance. Strategic initiatives and investments in technology are expected to drive future growth. Significant revenue growth and strategic initiatives indicate a likely positive shift in the company's market position.

20 Oct

3

Zepp Health Corporation will report its financial results for the third quarter of 2025 on November 4, 2025. Investors and analysts are likely to pay close attention to the results for insights into the company's performance and future outlook. Quarterly financial results can moderately influence investor sentiment and provide insights into the company's operational performance.

19 Oct

4

Zepp Health Corporation Sponsored ADR (ZEPP) has outperformed Apple in stock gains for 2025, attributed to its innovative fitness technology and strategic market positioning. The company's focus on health and wellness products has resonated well with consumers, leading to increased sales and investor interest. Analysts highlight Zepp's ability to capture market share in the competitive fitness tech sector, suggesting a strong growth trajectory compared to larger competitors like Apple. Zepp's innovative product offerings and market share growth are likely to significantly impact its future performance and investor sentiment.

29 Sep

3

Amazfit has expanded its HYROX athlete roster by signing global champions and rising stars, enhancing its brand presence in the fitness community. This initiative aims to promote the Amazfit brand and its products through partnerships with elite athletes, showcasing their commitment to fitness and performance. The expansion of the athlete roster may enhance brand visibility and market positioning, but its overall impact on financial performance is expected to be limited.

stockrow.com/ZEPP · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com